 Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD). Actavis intends to market Atomoxetine HCl in 10 mg, 18 mg, 25 mg, 40 mg, 6 ... ...
|
|
 Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ... ...
|
 (MedPage Today) -- At least half of children with severe, apparently treatment-resistant asthma can be successfully managed with conventional treatments using a thorough, multidisciplinary approach, researchers suggested. ... ...
|
 When your newborn infant is crying with uncomfortable teething or otherwise obviously suffering, feeding sugar to the little one has been a home remedy for years based on not only perceived behavior, but also physiological reactions. However, a new ... ...
|
|
 Millions of students at all grade levels, from elementary to high school to college, will head back to school and many times this is met with mixed emotions. Not because the "summer fun" has ended, but because school adds new pressures into the mix ... ...
|
 Nearly one out of every three American children is clinically overweight or obese. The health and well-being of future generations is undeniably at risk. And yet the fastest-growing fitness club chain in the world is about to launch a nationwide camp ... ...
|
 As the U.S. launches its first-ever National Childhood Obesity Awareness Month today, scientists say the problem may be even more widespread than was thought. Researchers have found that parents tend to underreport their children's weight. Estimates ... ...
|
|
|
<< Inizio < Prec. 1 2 3 4 5 6 7 8 9 10 Succ. > Fine >>
|
|
Pagina 1 di 457 |
